Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 2/20 | 0.50 |
| ▸ | PGK1 | P00558 | 1/20 | 0.48 |
| ▸ | PGK2 | P07205 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | HMGCR | P04035 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CETP | P11597 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | PTPRB | P23467 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6028463 | 0.88 | PPARD (0.44) | PPARDPGK1PGK2POLBHMGCR | |
| SCHEMBL17488978 | 0.86 | PPARD (0.50) | PPARDPGK1PGK2POLBTSHR | |
| SCHEMBL9549401 | 0.85 | PPARD (0.41) | PPARDPGK1PGK2POLBHMGCR | |
| SCHEMBL7046484 | 0.85 | PPARD (0.41) | PPARDPGK1PGK2POLB | |
| SCHEMBL915468 | 0.83 | PPARD (0.40) | PPARDTP53HDAC1CETP | |
| SCHEMBL915800 | 0.81 | TSHR (0.52) | PPARDPOLBTSHRCETP | |
| SCHEMBL915746 | 0.80 | KDM4E (0.46) | PPARDPOLBTDP1HDAC1MAPT | |
| SCHEMBL16790520 | 0.80 | HMGCR (0.48) | PPARDPGK1PGK2POLBTSHR | |
| SCHEMBL45804 | 0.80 | HMGCR (0.62) | POLBTSHRTP53HMGCRMAPT | |
| SCHEMBL914541 | 0.79 | PPARD (0.44) | PPARDPGK1PGK2POLBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060210479-A1 | Targeting chelants and chelates | DOW GLOBAL TECHNOLOGIES INC. (US) | 2006-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060210479-A1 | Targeting chelants and chelates | CLTC, CALCOCO2, TFRC | PPARD 2952/4885PGK1 2785/4885PGK2 2466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.